A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Celgene
National Cancer Institute (NCI)
Lund University Hospital
Johannes Gutenberg University Mainz
Jichi Medical University
National Cancer Institute (NCI)
Southern Europe New Drug Organization
Charite University, Berlin, Germany